What is ROIV's five-year median EV/EBITDA?

0.7x. Half of ROIV's weekly readings since February 2024 were higher and half were lower. This page has 220 weekly readings, from Aug 15, 2022 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ROIV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Roivant Sciences Ltd (ROIV) valuation history

Health Care

$37.52

Latest weekly close · Market cap $27.0B

Roivant Sciences' EV/EBITDA is unavailable because recent financial data is missing (as of Oct 30, 2026).

No P/E: earnings over the last twelve months are negative.
No P/S: recent financial data is missing.
No EV/Sales: recent financial data is missing.

No EV/EBITDA chart for ROIV right now

EV/EBITDA

n/mnot ranked

No EV/EBITDA rank: recent financial data is missing.

Growth, last 12 months vs the year before

Revenue: -68%decelerating
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ROIV EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	n/m	Too little history
Dec 30, 2024	0.7×	44
Dec 25, 2023	n/m	Too little history
Dec 26, 2022	n/m	Too little history

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare ROIV with peers

Health Care peers of ROIV on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
ABBVAbbVie	23.0×	Above its usual range	89
AMGNAmgen	20.8×	Historically high	99
ARWRArrowhead Pharmaceuticals Inc	n/m	Not ranked	n/m, not ranked
BIIBBiogen	26.3×	Historically high	100
BMRNBioMarin Pharmaceutical Inc	48.0×	Within its usual range	40

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on ROIV

No articles about ROIV yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ROIV's current EV/EBITDA?: Roivant Sciences' EV/EBITDA is unavailable because recent financial data is missing (as of Oct 30, 2026).
What is ROIV's five-year median EV/EBITDA?: 0.7x. Half of ROIV's weekly readings since February 2024 were higher and half were lower. This page has 220 weekly readings, from Aug 15, 2022 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ROIV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.